Moclobemide upregulated Bcl‐2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular‐regulated kinase pathway
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Moclobemide (MB) is an antidepressant drug that selectively and reversibly inhibits monoamine oxidase‐A. Recent studies have revealed that antidepressant drugs possess the characters of potent growth‐promoting factors for the development of neurogenesis and improve the survival rate of serotonin (5‐hydroxytrytamine; 5‐HT) neurons. However, whether MB comprises neuroprotection effects or modulates the proliferation of neural stem cells (NSCs) needs to be elucidated. In this study, firstly, we used the MTT (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide) assay to demonstrate that 50 μM MB can increase the cell viability of NSCs. The result of real‐time reverse transcription–polymerase chain reaction (RT–PCR) showed that the induction of MB can upregulate the gene expressions of Bcl‐2 and Bcl‐xL. By using caspases 8 and 3, ELISA and terminal dUTP nick‐end labeling (TUNEL) assay, our data further confirmed that 50 μM MB‐treated NSCs can prevent FasL‐induced apoptosis. The morphological findings also supported the evidence that MB can facilitate the dendritic development and increase the neurite expansion of NSCs. Moreover, we found that MB treatment increased the expression of Bcl‐2 in NSCs through activating the extracellular‐regulated kinase (ERK) phosphorylation. By using the triple‐staining immunofluorescent study, the percentages of serotonin‐ and MAP‐2‐positive cells in the day 7 culture of MB‐treated NSCs were significantly increased (P<0.01). Furthermore, our data supported that MB treatment increased functional production of serotonin in NSCs via the modulation of ERK1/2. In sum, the study results support that MB can upregulate Bcl‐2 expression and induce the differentiation of NSCs into serotoninergic neuron via ERK pathway. British Journal of Pharmacology (2006) 148, 587–598. doi:10.1038/sj.bjp.0706766
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Why stress is bad for your brain
Sapolsky, R. M. (1996) · Science · doi:10.1126/science.273.5276.749 · Cited by 1,306 · cited 2×
“MRI imaging studies also showed that hippocampal volume decreases in patients with depression and post-traumatic stress disorder (Sapolsky, 1996; Gurvits et al., 1996).”
BackgroundResultStress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons
Watanabe, Y., Gould, E., & McEwen, B. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)91597-8 · Cited by 1,212 · cited 1×
“Previous studies demonstrated that stress-induced atrophy and loss of hippocampal CA3 British Journal of Pharmacology vol 148 (5) pyramidal neurons may contribute to the pathogenesis of depression (Watanabe et al., 1992; Duman et al., 2000).”
BackgroundThe cellular neurobiology of depression
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001) · Nature Medicine · doi:10.1038/87865 · Cited by 1,182 · cited 2×
“Preliminary postmortem brain studies suggest the possible involvement of Bcl-2 in mood disorders, and the upregulation of Bcl-2 will exert trophic effects, and enhance cellular resilience, in the treatment of mood disorders (Manji et al., 2001; Bachmann et al., 2005).”
BackgroundAdult brain neurogenesis and psychiatry: a novel theory of depression
Jacobs, B. L., van Praag, H., & Gage, F. H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000712 · Cited by 964
Research and treatment approaches to depression
Wong, M.-L., & Licinio, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072566 · Cited by 656
Neuronal plasticity and survival in mood disorders
Duman, R. S., Malberg, J., Nakagawa, S., & D’Sa, C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00935-5 · Cited by 652
Jiang, W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25509 · Cited by 527
Kodama, M., Fujioka, T., & Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.008 · Cited by 387 · cited 1×
“Recent studies have further suggested that the behavioral effects of chronic use of antidepressant drugs may be mediated by the stimulation of neurogenesis in the hippocampmus of adult rats (Kodama et al., 2004).”
BackgroundHayley, S., Poulter, M. O., Merali, Z., & Anisman, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.051 · Cited by 324
MAP Kinase Activation by Fluoxetine and Its Relation to Gene Expression in Cultured Rat Astrocytes
Mercier, G., Lennon, A. M., Renouf, B., Dessouroux, A., Ramaugé, M., Courtin, F., & Pierre, M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:2:207 · Cited by 176 · cited 1×
“…shown that the mitogenactivated protein kinase (MAPK)/extracellular-regulated kinase (ERK) signaling pathways may be important for transcriptional activation and protein synthesis of neuronal survival and neuroplasticity in depression (Einat et al., 2003; Mercier et al., 2004; Hayley et al., 2005).”
Background
Cited by
Kubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J., & Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.026 · Cited by 443
Kosten, T. A., Galloway, M. P., Duman, R. S., Russell, D. S., & D'Sa, C. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301527 · Cited by 165
Golan, M., Schreiber, G., & Avissar, S. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168038 · Cited by 22
Amidfar, M., Kim, Y., Scaini, G., & Quevedo, J. (2018) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32623 · Cited by 16
Metadata
- Authors
- Chiou, S., Ku, H., Tsai, T., Lin, H., Chen, L., Chien, C., Ho, L. L. ‐., Lee, C., & Chang, Y.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-07
- Volume
- 148
- Issue
- 5
- Pages
- 587-598
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2000865963
- Cited by
- 74
- References
- 11
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Moclobemide upregulated Bcl‐2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular‐regulated kinase pathway. https://app.cochat.ai/papers/10.1038/sj.bjp.0706766
- The paper
- Chiou, S., Ku, H., Tsai, T., Lin, H., Chen, L., Chien, C., Ho, L. L. ‐., Lee, C., & Chang, Y. (2006). Moclobemide upregulated Bcl‐2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular‐regulated kinase pathway. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0706766
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.